NCT01344902View on ClinicalTrials.gov

An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

October 31, 2009

Conditions
Colon Cancer
Interventions
DRUG

hexaminolevulinate HCl

200mg hexaminolevulinate HCl capsule 6 hours before colonoscopy

Trial Locations (1)

81241

Klinikum München Pasing, Munich

Sponsors

Lead Sponsor

Photocure
All Listed Sponsors
lead

Photocure

INDUSTRY